John D. Shaughnessy Jr., Ph.D.
John Shaughnessy Jr. is a principal staff scientist and professor of medicine. He earned his doctorate in molecular biology from the University of Maryland and served his postdoctoral fellowship at the Mammalian Genetics Laboratory of the National Cancer Institute’s Frederick Cancer Research and Development Center. In 1996, he joined UAMS specifically to create a tissue archive and accompanying genetic profiles on myeloma patients. He rejoined UAMS in 2021.
His research focuses on developing new targeted therapies for multiple myeloma. Using the Myeloma Center’s patient cases, he investigates the genetics of extremely long survivors, seeking to understand their longevity.
David Mery, Ph.D.
David Mery is a postdoctoral fellow with the UAMS College of Medicine. He earned his doctorate in pharmaceutical sciences from UAMS in the summer of 2021 and joined the Myeloma Center that fall.
His research focuses on the pharmacokinetics and pharmacodynamics of small molecules for the discovery of therapies that can efficiently target and eliminate resistant myeloma cells. Mery is also working to understand the inter-tumor heterogeneity between multiple myeloma subtypes.